Paper39543742
Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors.
Udumula MP and 13 others. J Ovarian Res, 2024. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors. Papers, record 39543742. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39543742
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ovarian Neoplasms | Major topic |
| Mitochondria | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Xenograft Model Antitumor Assays | Major topic |
| Female | |
| Animals | |
| Humans | |
| Cell Line, Tumor | |
| Mice | |
| Mice, Nude | |
| Antineoplastic Agents | |
| Oxidative Phosphorylation | |
| Caprylates | |
| Sulfides |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| HT94252410245 | Department of Defense Ovarian Cancer Research Program | PubMed | ||
| HT94252410245 | Department of Defense Ovarian Cancer Research Program | PubMed | ||
| H10330 | Henry Ford Health Game on Cancer | PubMed | ||
| H10330 | Henry Ford Health Game on Cancer | PubMed |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34060699 | Molecular characteristics and tumorigenicity of ascites-derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer. | Mol Oncol | 2021 | https://conductscience.org/library/papers/34060699 | PubMed |
| 2 | 31900386 | Mitochondrial TCA cycle metabolites control physiology and disease. | Nat Commun | 2020 | https://conductscience.org/library/papers/31900386 | PubMed |
| 3 | 26454069 | Dysregulated metabolism contributes to oncogenesis. | Semin Cancer Biol | 2015 | https://conductscience.org/library/papers/26454069 | PubMed |
| 4 | 38181758 | The biochemical pathways of apoptotic, necroptotic, pyroptotic, and ferroptotic cell death. | Mol Cell | 2024 | https://conductscience.org/library/papers/38181758 | PubMed |
| 5 | 24946808 | Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation. | Oncotarget | 2014 | https://conductscience.org/library/papers/24946808 | PubMed |
| 6 | 30231564 | Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/30231564 | PubMed |
| 7 | 29430716 | Imoxin attenuates high fructose-induced oxidative stress and apoptosis in renal epithelial cells via downregulation of protein kinase R pathway. | Fundam Clin Pharmacol | 2018 | https://conductscience.org/library/papers/29430716 | PubMed |
| 8 | 22215552 | Fluorescence-activated cell sorting analysis of mitochondrial content, membrane potential, and matrix oxidant burden in human lymphoblastoid cell lines. | Methods Mol Biol | 2012 | https://conductscience.org/library/papers/22215552 | PubMed |
| 9 | 28495639 | Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial. | Lancet Oncol | 2017 | https://conductscience.org/library/papers/28495639 | PubMed |
| 10 | 36479231 | Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy. | Adv Radiat Oncol | 2023 | https://conductscience.org/library/papers/36479231 | PubMed |
| 11 | 34906193 | Blockade of glutamine-dependent cell survival augments antitumor efficacy of CPI-613 in head and neck cancer. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34906193 | PubMed |
| 12 | 12087111 | The key role of anaplerosis and cataplerosis for citric acid cycle function. | J Biol Chem | 2002 | https://conductscience.org/library/papers/12087111 | PubMed |
| 13 | 31512500 | Devimistat in combination with high dose cytarabine and mitoxantrone compared with high dose cytarabine and mitoxantrone in older patients with relapsed/refractory acute myeloid leukemia: ARMADA 2000 Phase III study. | Future Oncol | 2019 | https://conductscience.org/library/papers/31512500 | PubMed |
| 14 | 35326656 | Divergent Metabolic Effects of Metformin Merge to Enhance Eicosapentaenoic Acid Metabolism and Inhibit Ovarian Cancer In Vivo. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35326656 | PubMed |
| 15 | 32610612 | Targeting Altered Energy Metabolism in Colorectal Cancer: Oncogenic Reprogramming, the Central Role of the TCA Cycle and Therapeutic Opportunities. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32610612 | PubMed |
| 16 | 27120812 | Spheroid cancer stem cells display reprogrammed metabolism and obtain energy by actively running the tricarboxylic acid (TCA) cycle. | Oncotarget | 2016 | https://conductscience.org/library/papers/27120812 | PubMed |
| 17 | 34155273 | High fructose and streptozotocin induced diabetic impairments are mitigated by Indirubin-3-hydrazone via downregulation of PKR pathway in Wistar rats. | Sci Rep | 2021 | https://conductscience.org/library/papers/34155273 | PubMed |
| 18 | 37822507 | Intermittent fasting induced ketogenesis inhibits mouse epithelial ovarian cancer by promoting antitumor T cell response. | iScience | 2023 | https://conductscience.org/library/papers/37822507 | PubMed |
| 19 | 37841597 | An early glycolysis burst in microglia regulates mitochondrial dysfunction in oligodendrocytes under neuroinflammation. | iScience | 2023 | https://conductscience.org/library/papers/37841597 | PubMed |
| 20 | 36658431 | Acetyl-CoA metabolism in cancer. | Nat Rev Cancer | 2023 | https://conductscience.org/library/papers/36658431 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42698921 | Spatiotemporal control of mitoribosome-mediated metabolic reprogramming in cancer: implications for heterogeneity and therapeutic targeting. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42698921 | PubMed |
| 42627059 | Combination of lonidamine with devimistat induces synergistic antitumor effects in lung cancer via multifaceted disruption of cellular energy metabolism. | Oncol Rep | 2026 | https://conductscience.org/library/papers/42627059 | PubMed |
| 42610661 | Cell-Type-Resolved Proteomics Reveals Distinct Immune and Metabolic Programs Between Primary and Recurrent Ascites in HGSOC. | Proteomics Clin Appl | 2026 | https://conductscience.org/library/papers/42610661 | PubMed |
| 42554299 | Hyperpolarized [2-13C]Pyruvate Identifies a Mitochondria-Active Hepatocellular Carcinoma Phenotype With Vulnerability to Mitochondrial Inhibition. | NMR Biomed | 2026 | https://conductscience.org/library/papers/42554299 | PubMed |
| 42182411 | MechAInistic: A Reviewer-Supervised Multi-Agent LLM System for Auditable Mechanistic Drug-Hypothesis Generation. | bioRxiv | 2026 | https://conductscience.org/library/papers/42182411 | PubMed |
| 42033075 | Aging-Driven Immunosuppression: The Role of Tregs in the Ovarian Tumor Microenvironment. | Aging Cell | 2026 | https://conductscience.org/library/papers/42033075 | PubMed |
| 42005830 | Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. | Mol Ther Oncol | 2026 | https://conductscience.org/library/papers/42005830 | PubMed |
| 40966021 | Identification and validation of mitochondrial ferroptosis and immune microenvironment-related hub biomarkers in liver cirrhosis by integrated bioinformatics analysis. | Sci Prog | 2025 | https://conductscience.org/library/papers/40966021 | PubMed |
| 40861078 | Metabolic Reprogramming Shapes the Progression and Therapeutic Landscape of Ovarian Cancer. | Cancer Manag Res | 2025 | https://conductscience.org/library/papers/40861078 | PubMed |
| 40835655 | GPT2 mediates glutamine metabolism-driven metabolic alterations in platinum-resistant ovarian cancer cells. | Sci Rep | 2025 | https://conductscience.org/library/papers/40835655 | PubMed |
| 40725147 | Spatiotemporal Heterogeneity of Tumor Glucose Metabolism Reprogramming: From Single-Cell Mechanisms to Precision Interventions. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40725147 | PubMed |
| 40707948 | Unlocking the mitochondrial functional code: unraveling the pathogenesis of ovarian cancer and innovative targets to inhibit malignant behavior. | J Transl Med | 2025 | https://conductscience.org/library/papers/40707948 | PubMed |
| 40563592 | The Identification of a Key Regulator of Mitochondrial Metabolism, the LRPPRC Protein, as a Novel Therapeutic Target in SDHA-Overexpressing Ovarian Tumors. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40563592 | PubMed |
| 40363779 | Advances in α-Lipoic Acid for Disease Prevention: Mechanisms and Therapeutic Insights. | Molecules | 2025 | https://conductscience.org/library/papers/40363779 | PubMed |
| 39981670 | The Molecular Mechanism of a Complex1-induced Apoptosis in Cancer Cells of the Esophagus. | Curr Mol Med | 2026 | https://conductscience.org/library/papers/39981670 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CYCS | 54205 | PubTator's text mining | https://conductscience.org/library/genes/54205 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39543742
GET https://conductscience.org/api/papers/v1/39543742/references?page=2